Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
T-Mobile US Inc.

Start price
Target price
Perf. (%)
€117.00
30.07.21
€135.00
30.07.22
2.99%
23.08.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€84.60
30.07.21
€100.00
30.07.22
12.87%
04.08.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€84.60
30.07.21
-
30.07.22
13.32%
13.03.22

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€29.21
30.07.21
-
30.07.22
-65.27%
30.07.22

Could be worthwhile Investment >10% per year
buy
RWE AG ST

Start price
Target price
Perf. (%)
€30.02
29.07.21
€34.00
29.07.22
2.76%
03.10.21

Sustainability is important
Top 10 in its market
Few uniques
Higher risks for its business
TAL Education Group ADR

Start price
Target price
Perf. (%)
€5.10
29.07.21
-
29.07.22
-5.10%
07.08.21

Probably not worthwhile Investment
buy
McPhy Energy S.A.

Start price
Target price
Perf. (%)
€15.90
29.07.21
€19.00
29.07.22
-16.89%
13.07.22

Future proof or reliable business model
Higher risks for its business
Lower EBIT Margin than peer group
High valuation
buy
Baozun Inc ADR

Start price
Target price
Perf. (%)
€22.00
29.07.21
€20.00
29.07.22
-32.27%
01.11.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€5.85
29.07.21
€7.00
29.07.22
-14.27%
01.11.21

Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€4.53
29.07.21
€4.40
29.07.22
-25.02%
23.05.22

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
buy
Alten S.A.

Start price
Target price
Perf. (%)
€133.10
29.07.21
€126.00
29.07.22
-1.50%
30.07.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.38
29.07.21
-
28.07.22
-72.64%
29.07.22

Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€239.60
29.07.21
€300.00
29.07.22
3.26%
08.09.21

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Tesla Inc

Start price
Target price
Perf. (%)
€182.13
29.07.21
-
29.07.22
34.26%
13.03.22

buy
ArcelorMittal S.A. ADR

Start price
Target price
Perf. (%)
€29.80
29.07.21
-
29.07.22
-8.72%
13.03.22

buy
Spotify Technology SA

Start price
Target price
Perf. (%)
€189.65
29.07.21
-
29.07.22
-38.83%
13.03.22

Realtech AG

Start price
Target price
Perf. (%)
€2.24
28.07.21
-
28.07.22
-13.39%
05.08.21

Probably not worthwhile Investment
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€3.01
28.07.21
-
28.07.22
-7.64%
07.08.21

Probably not worthwhile Investment
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.92
28.07.21
-
28.07.22
-25.00%
06.01.22

Probably not worthwhile Investment
High valuation
buy
Tick Trading Software AG

Start price
Target price
Perf. (%)
€43.00
28.07.21
-
28.07.22
-67.67%
29.07.22

buy
Tui AG

Start price
Target price
Perf. (%)
€40.67
28.07.21
-
28.07.24
-27.88%
21.04.22

Could be worthwhile Investment >10% per year
buy
Vonovia SE ADR

Start price
Target price
Perf. (%)
€27.80
28.07.21
-
28.07.22
-15.11%
17.01.22

Small cyclical dependencies
Market Leader or Top 3
Higher risks for its business
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.76
28.07.21
-
28.07.22
35.23%
29.07.21

Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Kiora Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€108.80
28.07.21
-
28.07.22
-94.78%
29.07.22

Could be worthwhile Investment >10% per year
High valuation
Sustainability is little important
high free float
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€75.60
28.07.21
€80.00
28.07.22
4.76%
16.08.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
High valuation